Published in Vaccine Weekly, July 12th, 2006
"Human papillomavirus (HPV) is the etiologic agent for cervical cancer. In Mexico, a woman dies every 2 h, and since 1990 the statistics have shown that the numbers of deaths are increasing," wrote E. Garcia-Hernandez and colleagues, Hospital de Gineco Obstetricia.
They continued, "We conducted a phase II clinical trial to evaluate the potential use of the MVA E2 recombinant vaccinia virus in treating high-grade lesions (CIN 2 and CIN 3) associated with oncogenic...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly